Enhanced operational and financial flexibility through existing credit amendment ...
A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...
HealthDay on MSN1d
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast CancerThe U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc., and Cullinan Therapeutics, Inc. have announced the successful outcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback